These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 27325686)

  • 1. ST-11: A New Brain-Penetrant Microtubule-Destabilizing Agent with Therapeutic Potential for Glioblastoma Multiforme.
    Cherry AE; Haas BR; Naydenov AV; Fung S; Xu C; Swinney K; Wagenbach M; Freeling J; Canton DA; Coy J; Horne EA; Rickman B; Vicente JJ; Scott JD; Ho RJ; Liggitt D; Wordeman L; Stella N
    Mol Cancer Ther; 2016 Sep; 15(9):2018-29. PubMed ID: 27325686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma.
    Ciesielski MJ; Bu Y; Munich SA; Teegarden P; Smolinski MP; Clements JL; Lau JYN; Hangauer DG; Fenstermaker RA
    J Neurooncol; 2018 Dec; 140(3):519-527. PubMed ID: 30238350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of (2E,5Z)-5-(2-hydroxybenzylidene)-2-((4-phenoxyphenyl)imino) thiazolidin-4-one, a novel microtubule-depolymerizing agent, in U87MG human glioblastoma cells and corresponding mouse xenograft model.
    Zhang Q; Liu X; Li X; Li C; Zhou H; Yan B
    J Pharmacol Sci; 2013; 122(3):223-31. PubMed ID: 23877018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.
    Du S; Sarver JG; Trabbic CJ; Erhardt PW; Schroering A; Maltese WA
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):237-254. PubMed ID: 30426158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems.
    Toren A; Pismenyuk T; Yalon M; Freedman S; Simon AJ; Fisher T; Moshe I; Reichardt JK; Constantini S; Mardor Y; Last D; Guez D; Daniels D; Assoulin M; Mehrian-Shai R
    Oncotarget; 2016 Nov; 7(46):74860-74871. PubMed ID: 27556862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model.
    Benedetti E; Antonosante A; d'Angelo M; Cristiano L; Galzio R; Destouches D; Florio TM; Dhez AC; Astarita C; Cinque B; Fidoamore A; Rosati F; Cifone MG; Ippoliti R; Giordano A; Courty J; Cimini A
    Oncotarget; 2015 Dec; 6(39):42091-104. PubMed ID: 26540346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
    Khan M; Yi F; Rasul A; Li T; Wang N; Gao H; Gao R; Ma T
    IUBMB Life; 2012 Sep; 64(9):783-94. PubMed ID: 22837216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulation of Small Drugs in a Supramolecule Enhances Solubility, Stability, and Therapeutic Efficacy Against Glioblastoma Multiforme.
    Tsiailanis AD; Renziehausen A; Karakurt S; Crook T; Syed N; Tzakos AG
    Methods Mol Biol; 2021; 2207():175-186. PubMed ID: 33113136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting βIII-tubulin in glioblastoma multiforme: from cell biology and histopathology to cancer therapeutics.
    Katsetos CD; Draber P; Kavallaris M
    Anticancer Agents Med Chem; 2011 Oct; 11(8):719-28. PubMed ID: 21707498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
    Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
    Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells.
    Dorsey JF; Mintz A; Tian X; Dowling ML; Plastaras JP; Dicker DT; Kao GD; El-Deiry WS
    Mol Cancer Ther; 2009 Dec; 8(12):3285-95. PubMed ID: 19996278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of
    Chahla C; Rima M; Mouawad C; Roufayel R; Kovacic H; El Obeid D; Sabatier JM; Luis J; Fajloun Z; El-Waly B
    Molecules; 2024 Aug; 29(16):. PubMed ID: 39203027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects.
    Lin XM; Shi XX; Xiong L; Nie JH; Ye HS; Du JZ; Liu J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.
    Bell JB; Eckerdt FD; Alley K; Magnusson LP; Hussain H; Bi Y; Arslan AD; Clymer J; Alvarez AA; Goldman S; Cheng SY; Nakano I; Horbinski C; Davuluri RV; James CD; Platanias LC
    Mol Cancer Res; 2016 Oct; 14(10):984-993. PubMed ID: 27364770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel synthetic chalcones induces apoptosis in human glioblastoma cells.
    Bittencourt LF; Oliveira KA; Cardoso CB; Lopes FG; Dal-Cim T; Chiaradia-Delatorre LD; Mascarello A; Maluf SW; Yunes RA; Garcez RC; Tasca CI; Nedel CB
    Chem Biol Interact; 2016 May; 252():74-81. PubMed ID: 27012433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis.
    Yang CH; Wang Y; Sims M; Cai C; He P; Yue J; Cheng J; Boop FA; Pfeffer SR; Pfeffer LM
    Oncotarget; 2016 Dec; 7(51):84017-84029. PubMed ID: 27705947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epothilone B inhibits migration of glioblastoma cells by inducing microtubule catastrophes and affecting EB1 accumulation at microtubule plus ends.
    Pagano A; Honoré S; Mohan R; Berges R; Akhmanova A; Braguer D
    Biochem Pharmacol; 2012 Aug; 84(4):432-43. PubMed ID: 22634050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.
    Gravina GL; Mancini A; Mattei C; Vitale F; Marampon F; Colapietro A; Rossi G; Ventura L; Vetuschi A; Di Cesare E; Fox JA; Festuccia C
    Oncotarget; 2017 May; 8(18):29865-29886. PubMed ID: 28415741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethoxycurcumin Suppresses Human Brain Glioblastoma Multiforme GBM 8401 Cell Xenograft Tumor in Nude Mice
    Huang YP; Ma YS; Kuo CL; Liao CL; Chen PY; Peng SF; Hsu FT; Lai KC
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.